In addition, (R)2-hydroxyglutarate (R-2HG), a cancer metabolite associated with mutant isocitrate dehydrogenases(IDH) in leukemias and gliomas, exerts anti-tumor effects by suppressing FTO and increasing total levels of m6A [24]. The gene discussed is IDH1; the disease is central nervous system cancer.